ASH Letter to FDA on Real-World Evidence Considerations re Non-Interventional Studies for Products
Jun 17
2024
American Society of Hematology. (2024).
ASH Letter to FDA on Real-World Evidence Considerations re Non-Interventional Studies for Products.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-on-real-world-evidence-considerations-re-non-interventional-studies-for-products.
American Society of Hematology.
"ASH Letter to FDA on Real-World Evidence Considerations re Non-Interventional Studies for Products." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-on-real-world-evidence-considerations-re-non-interventional-studies-for-products
(label-accessed October 27, 2024).
"American Society of Hematology."
ASH Letter to FDA on Real-World Evidence Considerations re Non-Interventional Studies for Products, 27 Oct. 2024 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-on-real-world-evidence-considerations-re-non-interventional-studies-for-products.
